Filter Results:
(208)
Show Results For
- All HBS Web
(1,405)
- Faculty Publications (208)
Show Results For
- All HBS Web
(1,405)
- Faculty Publications (208)
←
Page 11 of 208
Results
- October 1997 (Revised April 2002)
- Case
Planned Parenthood Federation of America (A)
By: V. Kasturi Rangan and Elaine V. Backman
Outlines the dynamic shifts in the external environment surrounding Planned Parenthood's operations in 1994. Health care reform was threatening some of its core customer base. The organization had to come up with a strategy and a process for adapting to the new... View Details
Rangan, V. Kasturi, and Elaine V. Backman. "Planned Parenthood Federation of America (A)." Harvard Business School Case 598-001, October 1997. (Revised April 2002.)
- October 1995
- Case
Singapore TradeNet: Beyond TradeNet to the Intelligent Island
By: Lynda M. Applegate, John L. King and Soon-Siong Neo
Describes the actions taken by the government of Singapore to enable the country to survive and prosper after it achieved independence in the late 1960s. Recognizing that its small size, limited natural resources, but excellent location placed it in a vulnerable... View Details
Keywords: Transition; Communication Technology; Governing Rules, Regulations, and Reforms; Policy; Digital Platforms; Information Technology; Technology Adoption; Information Technology Industry; Singapore
Applegate, Lynda M., John L. King, and Soon-Siong Neo. "Singapore TradeNet: Beyond TradeNet to the Intelligent Island." Harvard Business School Case 196-105, October 1995.
- September 1995
- Case
Ares-Serono
By: Michael Y. Yoshino, Jean-Pierre Jeannet and Carin-Isabel Knoop
Ares Serono, a medium-size Swiss pharmaceutical company, is the global leader in the field of fertility drugs. The company has successfully transformed into one of the very few biotech firms in Europe. The case treats a set of major strategic and organizational... View Details
Keywords: Geographic Location; Globalized Firms and Management; Asset Management; Balance and Stability; Expansion; Digital Platforms; Leadership Development; Health Care and Treatment; Transformation; Family Business; Problems and Challenges; Pharmaceutical Industry; Biotechnology Industry; Switzerland; Europe
Yoshino, Michael Y., Jean-Pierre Jeannet, and Carin-Isabel Knoop. "Ares-Serono." Harvard Business School Case 396-035, September 1995.
- September 1991 (Revised February 1993)
- Case
Burroughs Wellcome and AZT (A)
Burroughs Wellcome Co., developer of AZT, the first drug approved by the U.S. Food and Drug Administration for the treatment of Acquired Immune Deficiency Syndrome (AIDS), finds itself under siege in September 1989 by AIDS activists and various segments of the U.S.... View Details
Keywords: Governing Rules, Regulations, and Reforms; Ethics; Business and Government Relations; Communication Strategy; Health Care and Treatment; Monopoly; Intellectual Property; Research and Development; Price; Pharmaceutical Industry; London
Emmons, Willis M., III. "Burroughs Wellcome and AZT (A)." Harvard Business School Case 792-004, September 1991. (Revised February 1993.)
- Forthcoming
- Article
Confronting the Limits of Symbolic Actions: How Entrepreneurs Narrow the Presentation-Performance Gap
By: Rebecca Karp and Siobhan O'Mahony
Entrepreneurs often skillfully leverage symbolic actions to manage impressions and gain acceptance for their innovations. Impression management can generate interest, but also heighten expectations beyond an innovation’s capabilities, creating a gap between... View Details
- Research Summary
Current Research
By: Leslie K. John
Professor John is a behavioral scientist who uses both laboratory and field experiments to investigate questions that are at the intersection of marketing, organizational behavior, and public policy.
Professor John’s work has been published in leading... View Details
- Forthcoming
- Article
Disclosure, Humanizing, and Contextual Vulnerability of Generative AI Chatbots
By: Julian De Freitas and I. Glenn Cohen
In the wake of recent advancements in generative AI, regulatory bodies are trying to keep pace. One key decision is whether to require app makers to disclose the use of generative AI-powered chatbots in their products. We suggest that some generative AI-based chatbots... View Details
- Teaching Interest
Overview
By: Leemore S. Dafny
U.S. Healthcare Strategy
The U.S. healthcare sector accounts for 17 percent of GDP, and encompasses a diverse set of industries with public, nonprofit, and for-profit buyers and sellers. There are significant concerns about high and rising spending, and... View Details
- ←
- 11